Cargando…
Awakening of SCHLAFEN 11 by immunohistochemistry: a new biomarker predicting response to chemotherapy
Autor principal: | Buettner, Reinhard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7973391/ https://www.ncbi.nlm.nih.gov/pubmed/33566168 http://dx.doi.org/10.1007/s00428-021-03051-3 |
Ejemplares similares
-
The role of Schlafen 11 (SLFN11) as a predictive biomarker for targeting the DNA damage response
por: Coleman, Niamh, et al.
Publicado: (2020) -
Prognostic impact of Schlafen 11 in bladder cancer patients treated with platinum‐based chemotherapy
por: Taniyama, Daiki, et al.
Publicado: (2021) -
Retrospective analysis of Schlafen11 (SLFN11) to predict the outcomes to therapies affecting the DNA damage response
por: Willis, Sophie E., et al.
Publicado: (2021) -
Human Schlafen 11 inhibits influenza A virus production
por: Jitobaom, Kunlakanya, et al.
Publicado: (2023) -
Structural and biochemical characterization of Schlafen11 N-terminal domain
por: Hou, Pengjiao, et al.
Publicado: (2023)